CERT vs PSA · rev $385.1M vs rev $4.82B
Certara Inc (CERT) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Certara Inc (CERT) is a health information services company listed on US.
PSA (PSA) common stock.
Latest reported CERT revenue for 2024-12-31 was $385.1M. Net income was -$12.1M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. CERT currently screens at market cap $1.86B.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CERT currently screens at market cap $1.86B. PSA currently screens at market cap $0.
Not investment advice. Open the CERT and PSA stock pages for the full models.
Not investment advice.